Neptune Medical

Neptune Medical is a venture capital-funded medical device start-up. The company develops, manufactures, and commercializes high-volume, high-clinical utility, single-use medical devices for gastroenterology. Their innovative devices are designed to improve patient outcomes and enhance the precision and safety of minimally invasive procedures.

Health Care Medical Medical Device Robotics


Funding Amount: $97M

Funding Type: Series D

Funding Date: 2024-08-15

City & State: Burlingame, California

Country United States

Employee Count: 123


Unlock founder details & tech stack data with a premium subscription.

Similar Startups

XP Health
XP Health Logo

XP Health uses augmented reality, customer-centric design, and care navigation to offer a vision care platform that is a virtual-first approach for eye care and eyewear that can work as a standalone benefit or alongside any vision insurance plan and allows one to find in-person eye exams, take an online vision acuity test to renew prescriptions online and find personalized glasses, providing employees and their families with access to good-quality, comprehensive vision care at significantly lower costs while expanding their coverage.

Piace Technology
Piace Technology Logo

Pieces is a healthcare artificial intelligence and technology company that connects health systems and the community to address clinical and social determinants of health through community networks and intelligent software and services.

Segmed
Segmed Logo

Segmed offers extensive clinical data and diagnostic-grade medical images to support life sciences and technology industries. The company facilitates rapid discovery and development of predictive models, improving patient recruitment and data management. Its solutions cater to pharmaceutical and medical device sectors, enhancing research andregulatory processes.

Talus Biosciences
Talus Biosciences Logo

Talus Bio is a drug discovery biotech startup working on drug development for gene regulators. The company integrates functional proteomics, automated biology, and machine learning to target challenging cancer transcription factors.